| Issue |
Section |
Title |
File |
| Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Comparative analysis of dexamethasone and methylprednisolone efficacy in induction therapy of childhood acute lymphoblastic leukemia: Results of ALL-MB 2002 multicenter study |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Therapy of childhood T-cell acute lymphoblastic leukemia: Experience gained by the Russian-Byelorussian cooperative group |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Experience in the treatment of young adults with acute lymphoblastic leukemia by ALL-MB-Minsk 2010 protocol |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Prognostic value of minimal residual disease in childhood B-precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 3 (2015) |
ACUTE LEUKEMIA |
Incidence of acute lymphoblastic leukemia in children in Azerbaijan Republic: Epidemiology and comparative analysis |
(Rus)
|
| Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
Allogeneic transplantation of hematopoetic stem cells in acute leukemia in children, adolescents and young adults in the Republic of Belarus |
(Rus)
|
| Vol 20, No 1 (2021) |
PROMISING STUDIES |
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
A hypodiploid karyotype in childhood B-cell precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 20, No 4 (2021) |
ORIGINAL ARTICLES |
Long-term outcome and surrogate molecular signatures of pediatric patients with diffuse astrocytomas |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
Hodgkin's lymphoma in children and adolescents in Belarus Republic: 23-year survival rate of 606 pediatric patients |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study |
(Rus)
|
| Vol 21, No 4 (2022) |
LITERATURE REVIEW |
Epidemiological aspects in cancer registration systems in Russia and around the world |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
